1 / 7

Urinary Antibacterial and Antiseptic Pharmaceuticals Market Growth and Segments, 2016-2026

Urinary tract infection refers to bacterial infection in any part of urinary system such as urethra, ureters, bladder and kidney. Urinary tract infections are common in patients which are using urinary catheter, diabetics and elderly people having compromised immunity. Most of the urinary infections are caused by E. coli and S. aureus. Urinary tract infections are mostly treated with antibacterial drugs such as ciprofloxacin, azithromycin, penicillin and others. Urinary antiseptics such as nalidixic acid, nitrofurantoin etc. can also be effectively used for management of urinary tract infections, these are the drugs which are excreted in urine and show their antiseptic action in the bladder. The choice of treatment depends on type of infectious bacteria and patient history, complicated urinary tract infections leads to kidney damage and may need hospitalization. According to National Institute of Diabetes, Digestive and Kidney Diseases (NIH), urinary tract infection is the second most common type of infection and approximately 8.1 Mn patients visit every year to their physician concerning urinary tract infection.

Ethan_smith
Download Presentation

Urinary Antibacterial and Antiseptic Pharmaceuticals Market Growth and Segments, 2016-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Urinary Antibacterial and Antiseptic Pharmaceuticals Market Share, Global Trends, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2016 Future Market Insights www.futuremarketinsights.com sales@futuremarketinsights.com

  2. Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Research Capabilities Subscription Information Sector Coverage • Automotive and Transportation • Electronics, Semiconductor, and ICT • Retail and Consumer Products • Industrial Automation and Equipment • Customized Research • Syndicated Research • Investment Research • Social Media Research • Chemicals & Materials • Food and Beverages • Services and Utilities • Energy, Mining, Oil, and Gas Customized Research Syndicated Research Investment Research Social Media Research For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com

  3. Report Description Report Description Urinary tract infection refers to bacterial infection in any part of urinary system such as urethra, ureters, bladder and kidney. Urinary tract infections are common in patients which are using urinary catheter, diabetics and elderly people having compromised immunity. Most of the urinary infections are caused by E. coli and S. aureus. Urinary tract infections are mostly treated with antibacterial drugs such as ciprofloxacin, azithromycin, penicillin and others. Urinary antiseptics such as nalidixic acid, nitrofurantoin etc. can also be effectively used for management of urinary tract infections, these are the drugs which are excreted in urine and show their antiseptic action in the bladder. The choice of treatment depends on type of infectious bacteria and patient history, complicated urinary tract infections leads to kidney damage and may need hospitalization. According to National Institute of Diabetes, Digestive and Kidney Diseases (NIH), urinary tract infection is the second most common type of infection and approximately 8.1 Mn patients visit every year to their physician concerning urinary tract infection. Urinary Antibacterial and Antiseptic Pharmaceuticals Market: Drivers and Restraints Increasing recurrence rate for urinary tract infections is the major driver for the growth of urinary antibacterial and antiseptic pharmaceuticals market. Other factors influencing growth of urinary antibacterial and antiseptic pharmaceuticals market can be increasing incidence of diabetes, rising cases of catheter-associated urinary tract infections and expanding indications of drugs, availability of combination products, etc. According to Center for Disease Control and Prevention (CDC), 75% of the hospital acquired urinary tract infections are associated with the catheter use. Major restraint for growth of global market for urinary antibacterial and antiseptic pharmaceuticals is increasing bacterial resistance to antibiotics.

  4. Report Description Report Description Request Free Report Sample@http://www.futuremarketinsights.com/reports/sample/rep-gb-1451 Urinary Antibacterial and Antiseptic Pharmaceuticals Market: Segmentation The global urinary antibacterial and antiseptic pharmaceuticals market is classified on the basis of product type, distribution channel and geography. Based on product type, the global urinary antibacterial and antiseptic pharmaceuticals market is segmented as follows: Antibacterial Antiseptic Based on distribution channel, the global urinary antibacterial and antiseptic pharmaceuticals market has been segmented as follows: Hospital pharmacies Pharmacy & Drugstores E-commerce Request For TOC@http://www.futuremarketinsights.com/toc/rep-gb-1451 Urinary Antibacterial and Antiseptic Pharmaceuticals Market: Overview

  5. Report Description Report Description The global urinary antibacterial and antiseptic pharmaceuticals market is expected to witness sluggish growth due to huge competition between generic players in major markets. Antibacterial product segment is anticipated to hold maximum market as it is the first line treatment for urinary tract infections. Hospital end user segment will continue to lead the global market for urinary antibacterial and antiseptic pharmaceuticals market due to increasing usage of urinary catheters among patients. According to CDC data, 15-25% of all hospitalized patients require catheter use during their hospital stay. Several new treatment options such as monoclonal antibodies are being developed for infection which can influence the market. Urinary Antibacterial and Antiseptic Pharmaceuticals Market: Region-wise Outlook Geographically, the global urinary antibacterial and antiseptic pharmaceuticals market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. Europe is anticipated to lead the global market for urinary antibacterial and antiseptic pharmaceutical due to greater incidence community acquired urinary tract infections, followed by North America. However, the market is expected to register decline in revenue in the regions of North America and Europe. The Asia Pacific market for urinary antibacterial and antiseptic pharmaceuticals is anticipated to exhibit moderate growth. Browse All Syndicated Market Research Reports@http://www.futuremarketinsights.com/reports

  6. Report Description Report Description Urinary Antibacterial and Antiseptic Pharmaceuticals Market: Key Players Some of the key market players in global urinary and antiseptic pharmaceuticals market are Pfizer Inc., AstraZeneca Plc., Merck & Co., GlaxoSmithKline Plc., Bayer Pharma AG, Johnson & Johnson Private Limited, Daiichi Sankyo Company Limited and others.

  7. Thank You! To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com Future Market Insights:616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 | D: +1-845-579-5705

More Related